Revvity | PKI - Gross Profit On Sales


Revvity reported $416.87M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
Align Technology USD 757.43M 20.84M Jun/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 309.4M 35.8M Mar/2026
Bruker USD 416M 36.2M Jun/2026
Celltrion KRW 39.29B 7.7B Mar/2026
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Danaher USD 3.61B 20M Jun/2026
Dentsply International USD 493M 66M Jun/2026
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Edwards Lifesciences USD 1.35B 62.6M Jun/2026
Illumina USD 770M 49M Jun/2026
Intuitive Surgical USD 2.02B 193.4M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Laboratory Of America USD 1.11B 98.2M Jun/2026
Medical Developments International AUD 7.35M 7.37M Jun/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 555.82M 119.62M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Organigram Holdings CAD 16.41M 6.91M Mar/2026
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Pharma Mar EUR 44.87M 5.63M Jun/2026
Qiagen NV USD 309.6M 15.67M Mar/2026
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD 223.9M 315.7M Jun/2026
Repligen USD 110.04M 1.75M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
Sartorius EUR 433.1M 18.6M Jun/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tilray USD 57.47M 10.16M Jun/2025
Waters USD 490M 52M Jun/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026